August 12, 2013 4:35 PM | 1 min read
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced thatC. Randal Mills, Ph.D., President and Chief Executive Officer, will host aconference call to discuss the results of the interim analysis of itsmulticenter, randomized, controlled trial evaluating the efficacy and safetyof Grafix® for the treatment of chronic diabetic foot ulcers. The call will beheld tomorrow, August 13, 2013 at 9:00 a.m. ET.To access the webcast, visit the Investor Relations section of the company'swebsite at http://investor.osiris.com/events.cfm. Alternatively, callers mayparticipate in the conference call by dialing (877) 303-6133 (U.S.participants) or (970) 315-0493 (international participants).An archive of the webcast will be available approximately two hours after thecompletion of the call. To access the archived webcast, visit the InvestorRelations section of the company's website athttp://investor.osiris.com/events.cfm.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.